[ad_1]
Bahrain News Agency said: “The National Regulatory Authority for Health Professions and Services today approved the emergency use of the vaccine produced by Pfizer and Biontech against the coronavirus (Covid-19) , making the Kingdom the second country in the world to allow the use of this vaccine. “
The agency said the vaccine will be available to “groups most at risk for complications from the Coronavirus, including the elderly, people with chronic illnesses and other groups determined by the health ministry in the purpose of providing anti-virus vaccines “.
This was based on the study conducted by the National Regulatory Authority for Health Professions and Services and the Department of Health’s Immunization Committee in light of information provided by Pfizer on the results it monitored. for the vaccine in terms of safety and efficacy.
Last November, Bahrain approved the use of the Sinopharm vaccine to immunize frontline workers.
A few days ago, the British authorities announced the granting of the necessary licenses for the Pfizer-Biontech vaccine, so that anyone over the age of 16 can receive the doses, except for pregnant women due to the lack of data on its impact on fetuses so far.
And last November, Pfizer announced that its Corona vaccine, which it is developing with Biontech, is over 90% effective.
Speaking at a press conference, Ben Osborne, head of the UK branch of Pfizer, said: “We are actually not disclosing any details on any aspect of this agreement, in particular the terms of liability.”
When asked when Pfizer will release full data from a clinical trial for the vaccine, she said work is underway in this context.
[ad_2]
Source link
